Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Monolaurin, a monoglyceride derived from lauric acid (found in coconut oil), has garnered interest for its potential antiviral properties, including use against herpes simplex virus (HSV), the cause of cold sores. Several in vitro studies have demonstrated that monolaurin can disrupt the lipid envelope of certain viruses, including HSV-1, thereby inactivating them. For example, research published in Antimicrobial Agents and Chemotherapy has shown that monolaurin can reduce viral infectivity in cell cultures.

Despite these promising laboratory findings, there is limited direct clinical evidence supporting the use of monolaurin as a treatment or preventative for cold sores in humans. No large-scale, peer-reviewed randomized controlled trials have confirmed its efficacy or safety for this specific use. Most of the evidence remains preclinical, and while mechanistically plausible, this does not guarantee similar results in real-world scenarios.

In summary, while there is some scientific rationale and laboratory evidence suggesting monolaurin may help manage cold sores by targeting the virus responsible, the current level of clinical support is weak (rated 2 out of 5). Individuals considering monolaurin for cold sores should be aware of the gap between laboratory data and proven clinical benefit, and should consult a healthcare provider for guidance.

More about monolaurin
More about Cold Sores

Other ingredients used for Cold Sores

Other health conditions supported by monolaurin

Products containing monolaurin